X
29Jul

National Retailer Pulls CBD Products From Shelves in Response to FDA Warning to Product Manufacturer

On Monday, July 22, the U.S. Food and Drug Administration (FDA) took a rare and significant step in issuing a warning letter to Curaleaf Holdings, Inc. (Curaleaf), one of the country’s larger producers of CBD-based products, regarding Curaleaf’s...
By: Manatt, Phelps & Phillips, LLP
Source Url: https://www.jdsupra.com/legalnews/national-retailer-pulls-cbd-products-45233/

Related

US Department of Labor finalizes updated overtime pay regulations

In the three-year old saga regarding anticipated changes to the minimum salary threshold for overtim...

Read More >

Responding to the Coronavirus (2019-nCoV) Outbreak: Best Practices for Employers

The 2019 Novel Coronavirus (“2019-nCoV” or “Coronavirus”) is a rapidly spreading respiratory ill...

Read More >

Changes in Employment Laws in Massachusetts

Keeping an eye on changes and trends in employment law is an excellent way for businesses to mitigat...

Read More >

Demystifying Labor Commissioner Wage Claims

Seyfarth Synopsis: Halloween was last week, and you probably thought all the scary ghouls and goblin...

Read More >

Proposed Section 162(m) Rules Would Make More Post-IPO and Public Company Transaction-Based Executive Pay Nondeductible

The trend toward limiting U.S. federal income tax benefits associated with public company executive ...

Read More >

Establishing A Business Entity In England (Updated)

The attractiveness of the United Kingdom as a business location is unabated. There are many advantag...

Read More >